tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vigil Neuroscience downgraded to Hold from Buy at Stifel
PremiumThe FlyVigil Neuroscience downgraded to Hold from Buy at Stifel
2M ago
Hold Rating on Vigil Neuroscience Amid Sanofi Acquisition and VG-3927 Developments
Premium
Ratings
Hold Rating on Vigil Neuroscience Amid Sanofi Acquisition and VG-3927 Developments
2M ago
Vigil Neuroscience downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Vigil Neuroscience downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Vigil Neuroscience Enters Merger Agreement with Sanofi
PremiumCompany AnnouncementsVigil Neuroscience Enters Merger Agreement with Sanofi
2M ago
Vigil Neuroscience downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Vigil Neuroscience downgraded to Neutral from Buy at Guggenheim
2M ago
Vigil Neuroscience downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Vigil Neuroscience downgraded to Market Perform from Outperform at William Blair
2M ago
Vigil Neuroscience reports Q1 EPS (49c) vs. (50c) last year
PremiumThe FlyVigil Neuroscience reports Q1 EPS (49c) vs. (50c) last year
3M ago
Vigil Neuroscience sees cash runway into 2026
Premium
The Fly
Vigil Neuroscience sees cash runway into 2026
3M ago
Vigil presents data on oral small molecule program including VG-3927
Premium
The Fly
Vigil presents data on oral small molecule program including VG-3927
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100